Article: Digene Corporation Files Patent Suit Against Enzo Biochem.

GAITHERSBURG, Md. -- Digene Corporation today filed suit against Enzo Biochem in the United States District Court for the District of Delaware seeking a declaratory judgment that Enzo's U.S. Patent No. 6,221,581 B1 is not infringed by any of Digene's products and that the claims of the patent are invalid. Digene's suit was prompted by Enzo's threats of litigation.

"While we would have liked to avoid litigation," commented Evan Jones, Digene's CEO, "Enzo's threats left us without an option other than filing suit to protect our shareholders' interests. We believe that our products are free from any valid Enzo patent claims and expect to prevail in this action." ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!